Literature DB >> 6770625

Reduction of venous thrombosis complicating phlebography.

M A Bettmann, E W Salzman, D Rosenthal, P Clagett, G Davies, R Nebesar, K Rabinov, J Ploetz, J Skillman.   

Abstract

Patients who underwent radiographic phlebography were studied to determine the frequency of postphlebographic venous thrombosis. In a group of 23 patients who had negative phlebograms performed with standard contrast agent (60% sodium methylglucamine diatrizoate), nine had positive 125I-fibrinogen leg scans. On repeat phlebography, three had confirmed deep vein thrombosis, six overall developed deep or superficial thrombosis, and three had positive scans without demonstrable thrombi. In a second group of 34 patients studied with the contrast material diluted to 45%, only three developed positive scans, one due to deep venous thrombosis and two to superficial thrombosis. There was also a reduction in the incidence of postphlebographic symptoms of pain, tenderness, and erythema, but no apparent sacrifice in diagnostic accuracy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6770625     DOI: 10.2214/ajr.134.6.1169

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Roman Jaeschke; Scott M Stevens; Steven Goodacre; Philip S Wells; Matthew D Stevenson; Clive Kearon; Holger J Schunemann; Mark Crowther; Stephen G Pauker; Regina Makdissi; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Upper-extremity venography using digital subtraction angiography.

Authors:  M L Kinnison; S L Kaufman; R Chang; S Kadir; S E Mitchell; R I White
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

3.  Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary report.

Authors:  J A Klem; J V Schaffer; P D Crane; J A Barrett; G A Henry; L Canestri; M D Ezekowitz
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.